Mice of the C57BL/6J inbred strain develop thymic lymphomas at very high frequency after acute girradiation, while mice of several inbred strains derived from the wild progenitor of the Mus spretus species and their F1 hybrids with C57BL/6J appear extremely resistant. Analysis of the genetic determinism of the gradiation-induced thymic lymphoma (RITL) resistance with the help of inter-specific consomic strains (ICS), which carry a single introgressed Mus spretus chromosome on a C57BL/6J genetic background, provide significant evidence for the existence of a thymic lymphoma resistance (Tlyr1) locus on chromosome 19. The subsequent analysis of the backcross progeny resulting from a cross between consomic mice heterozygous for the Mus spretus chromosome 19 and C57BL/ 6J mice, together with the study of inter-specific recombinant congenic strains (IRCS), suggest that this Tlyr1 locus maps within the D19Mit60 -D19Mit40 chromosome interval. In addition to the discovery of a new locus controlling RITL development, our study emphasizes the value of ICS and IRCS for the genetic analysis of cancer predisposition.
Mice of the C57BL/6J inbred strain develop thymic lymphomas at very high frequency after acute girradiation, while mice of several inbred strains derived from the wild progenitor of the Mus spretus species and their F1 hybrids with C57BL/6J appear extremely resistant. Analysis of the genetic determinism of the gradiation-induced thymic lymphoma (RITL) resistance with the help of inter-specific consomic strains (ICS), which carry a single introgressed Mus spretus chromosome on a C57BL/6J genetic background, provide significant evidence for the existence of a thymic lymphoma resistance (Tlyr1) locus on chromosome 19. The subsequent analysis of the backcross progeny resulting from a cross between consomic mice heterozygous for the Mus spretus chromosome 19 and C57BL/ 6J mice, together with the study of inter-specific recombinant congenic strains (IRCS), suggest that this Tlyr1 locus maps within the D19Mit60 -D19Mit40 chromosome interval. In addition to the discovery of a new locus controlling RITL development, our study emphasizes the value of ICS and IRCS for the genetic analysis of cancer predisposition. Oncogene (2002 Oncogene ( ) 21, 6680 -6683. doi:10.1038 Keywords: mouse thymic lymphomas; tumor resistance genes; inter-specific consomic (ICS); recombinant congenic (IRCS) strains Mouse inbred strains differ in their predisposition to either spontaneous or carcinogen-induced thymic lymphomas (Richie et al., 1985; Newcomb et al., 1988; Okumoto et al., 1989; Szymanska et al., 1999) and, based on the analysis of these inter-strain differences, a few susceptibility loci to this type of tumors have been reported (Okumoto et al., 1990; Angel et al., 1993; Yamada et al., 1994; Wielowieyski et al., 1999; Mori et al., 2000; Saito et al., 2001; Angel and Richie, 2002) . However, considering that most of the laboratory strains are derived from a relatively small pool of ancestors, all belonging to the same Mus musculus group of species (Bonhomme and Gue´net, 1996) , the range of genotypic differences explored remain relatively limited. The analysis of cancer susceptibility performed with mice belonging to strains established from Mus spretus progenitors, as well as their hybrids with the highly susceptible inbred strain C57BL/6J (Newcomb et al., 1988) may be very useful to identify loci that confer resistance to RITL development, since inter-specific crosses have dramatically changed the situation making several new alleles amenable to genetic analysis (Balmain and Nagase, 1998) .
A total of 29 SPRET/Ei mice, 64 C57BL/6J and 62 (C57BL/6J x SPRET/Ei) F1 hybrids were g-irradiated and observed for thymic lymphomagenesis. Thymic lymphomas were induced by whole body g-irradiation distributed in four weekly doses of 1.75 Gy, starting with 35 -60-day-old mice. Thymic lymphoma development was observed in mice at weekly intervals beginning 12 weeks after g-irradiation and up to 26 weeks. Treated mice were sacrificed when they showed obvious signs of the disease, such as enlargement of spleen or lymph nodes detectable by palpation, hunched posture, shortness of breath, ruffled fur, or lethargy. Survivors were sacrificed at the end of the latency period (26 weeks). Thymus weight in excess of 100 mg at necropsy and serology of T-cell markers were used as criteria for the presence of thymic lymphoma in accordance with experiments previously described (Newcomb et al., 1988) . We found that only one out of 29 SPRET/Ei mice developed a tumor. In contrast, and as already observed in previous investigations, a much higher tumor rate was observed in mice of the C57BL/6J strain (47 out of 64 g-treated mice, 73.4%). Finally, in (C57BL/6J x SPRET/Ei) F1 hybrids, the occurrence of thymic lymphomas was close to that observed in SPRET/Ei mice with only three tumors out of 62 treated animals. Previous studies on genetic susceptibility to either skin tumors (Nagase et al., 1995 (Nagase et al., , 1999 or pulmonary adenomas (Manenti et al., 1996) have reported similar results using the same experimental approach. Taking all this evidence into account, little doubt remains that the Mus spretus mice carry dominant resistance alleles that confer protection against tumor formation to interspecific F1 hybrids with the classical laboratory strains.
In order to investigate in detail the determinism of the resistance/susceptibility phenotype, we used a set of heterozygous inter-specific consomic strains (or ICS) that were developed in our laboratory. Since these strains share the same C57BL/6J inbred genetic background but have a single chromosome substituted by its homologue from another strain or species (Mus spretus in our case), they represent ideal tools for the study of the genetic susceptibility to RITL development. Indeed, if a phenotype in ICS mice appears to deviate from what is known for the background strain, its genetic control must be related to a genetic determinant carried by the substituted chromosome. Chromosome substitution strains, which are equivalent to consomic lines, have recently proven useful for detecting germ-cell tumor (teratocarcinoma) susceptibility loci (Matin et al., 1999) . Inter-specific consomic strains (ICS) were generated by backcrossing, for at least 10 generations, the successive offspring of a cross initially set between a (STF/Pas x C57BL/6J) F1 female and a C57BL/6J male and selecting at each generation, with the help of microsatellite markers, those breeders that were carrying a single complete chromosome of Mus spretus origin. We attempted the construction of a complete set of 21 consomic strains, but breeding difficulties related to inter-specific epistatic interactions limited our success to chromosomes 14, 16 and 19 (this latter strain will be designated B6.Cs19 STF here after) as homozygous ICS. Most other chromosomes were available only as heterozygous animals carrying a single introgressed chromosome. ICS for chromosomes 4, 5, 7, 15, 17 and X, were lost during backcrossing. In this study, we report the results of a systematic analysis of thymic lymphoma susceptibility performed with consomic mice heterozygous for the Mus spretus chromosomes 2, 6, 9, 10, 13, 14 or 19 (Table 1) , because not enough animals were obtained from crosses with carriers of chromosomes 1, 3, 8, 11, 12, 16 and 18 . For most chromosomes we did not find any evidence of a change in susceptibility to RITL. However, we found that heterozygous consomics for chromosome 19 (B6.Cs19 STF /19 B6 ) appeared to differ significantly from C57BL/6J mice in their susceptibility to RITL (P=0.000009), suggesting the existence of at least one thymic lymphoma resistance (Tlyr1) locus on this chromosome.
To localize more precisely this Tlyr1 locus, we set a backcross between the resistant strain B6.Cs19 STF /19 B6 and the susceptible C57BL/6J strain (Figure 1 ). Contingency tables testing RITL incidence with respect to the inherited alleles showed the best P values for markers mapping within the interval defined by markers D19Mit60 and D19Mit40. This analysis gave suggestive (P50.0034), but not significant linkage (P50.0001) at D19Mit30 (P50.002) based on the criteria of Lander and Kruglyak (1995) for backcross analysis. Association of the tumor onset time (tumor latency) with inheritance of alleles at the Tlyr1 locus was analysed by the Kaplan -Meier/log-rank test to provide additional and statistical results. Mice with thymic lymphomas that inherited two copies of the C57BL/6J allele at the D19Mit30 locus (BB homozygotes) exhibited, on the average, a shorter latency period than those that inherited one copy of the Mus spretus allele and the other from C57BL/6J (BS heterozygotes) (Figure 2 ). On the other hand, we did not find any difference either in size or in the histological aspects of the tumors that could be related to the genetic constitution of the treated mice at the Tlyr1 locus. We did not find any difference in the serology of T-cell markers either. Having collected evidence for the possible location of a Tlyr1 locus on the proximal half of mouse chromosome 19 by backcross analysis, we tried to independently confirm our findings using an inter- (D19Mit60 -D19Mit40) . Given that the IRCS strains contain 1 -2% of the Mus spretus genome scattered throughout their genome, as revealed by extensive genotyping (to be described elsewhere), and given that not all chromosomes were examined in our survey of the ICS strains, one cannot formally rule out the possibility that other thymic lymphoma resistance loci of SEG/Pas (Mus spretus) origin exist on the co-introgressed segments of chromosomes 5, 6 and 13 in IRCS6A which might influence the observed effects. However, and even if recent data have concluded for weak linkage between the locus D5Mit5 (36 cM) and susceptibility to RITL (Saito et al., 2001) , we consider this possibility as very unlikely based on the fact that very similar results in RITL incidence were observed in B6.Cs19 STF /19 B6 mice (heterozygous consomics for Mus spretus chromosome 19). We also know after genotyping that, in IRCS 6A, the Mus spretus introgressed segment on mouse chromosome 5 does not expand very far distally beyond marker D5Mit48 (1 cM) indicating that the locus for susceptibility to RITL reported by Saito et al. (2001) is definitely of C57BL/6J origin in this IRCS. Similarly, the contribution of potential regions of chromosomes 6 and 13 in IRCS6A to the observed RITL resistance must be minimal, since no evidence of a resistance locus in these regions could be detected using B6.Cs6 STF and B6.Cs13 STF heterozygous consomics.
In the present study we used the Mus spretus and C57BL/6J strains of mice, which differ significantly in their RITL susceptibility to identify a resistance locus on chromosome 19. This finding contrasts with previous studies of genetic crosses involving the susceptible BALB/c strain and STS/A (Okumoto et al., 1990; Mori et al., 2000) or MSM (Saito et al., 2001) as the resistant parent, where four other distinct RITL loci located on chromosomes 4, 5 and 16, respectively, were identified. A similar situation was also observed in N-Methyl-N-nitrosourea-induced thymic lymphomas (Angel et al., 1993; Wielowieyski et al., 1999; Angel and Richie, 2002) . On the basis of these observations, it seems likely that distinct inbred mouse strains contain different thymic lymphoma resistance alleles.
As candidates for the Tlyr1 locus, the interval between D19Mit60 -D19Mit40 contains the programmed cell death-related Pdcd4 gene (20 cM), the pro-apoptotic Cd95 gene (23 cM) and the tumor suppressor Pten gene (23 cM). Pdcd4 is a gene that is known to be strongly expressed in the thymus (Shibahara et al., 1995) and to suppress neoplastic F1 x C57BL/6J ) N2 mice treated with g-irradiation. BS represents those N2 mice carrying both Mus spretus and C57BL/6J alleles for a given marker. BB indicates N2 mice carrying C57BL/6J alleles. RITL incidence with respect to the inherited alleles was tested in this backcross progeny in 2 x 2 contency tables for the indicated markers. The asterisk (*) denotes best P values. The position of each marker, indicated in cM, is taken from the Mouse Genome Database (http://www.informatics.jax. org). Genotyping was performed on tail DNA prepared by proteinase K digestion followed by phenol -chloroform extraction and ethanol precipitation. All microsatellite markers studied were amplified using primers obtained from the Mouse Genome Database. Amplifications were performed in a volume of 25 ml with a final concentration of 10 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 200 mM of each deoxynucleotide triphosphate, 0.2 mM of each primer and 0.5 units of Taq-polymerase (Finnzymes Inc., Finland). One hundred nanograms of tail DNA was used as template in each PCR reaction. All PCR amplifications were carried out with 30 cycles of 30 s at 948C, 30 s at 558C, and 1 min at 728C. Detection of the PCR products was performed by ethidium bromide staining of 3% agarose gels Figure 2 Genetic association of thymic lymphoma latency with D19Mit30. A total of 47 ((C57BL/6J x B6.Cs19 STF ) F1 x C57BL/6J) N2 mice with thymic lymphomas were distributed in two different genotype groups, one receiving two susceptibility alleles (BB) and the other a combination of one susceptibility and one resistance allele (BS). Curves for association of D19Mit30 alleles with tumor latency for these distributions were generated by the Kaplan -Meier method and analysed by logrank test transformation in mice (Yang et al., 2001) . Several findings support the involvement of Cd95 and Pten in thymic lymphomagenesis. For example, inactivation of Cd95 has been related to lymphoproliferation in lpr mice (Watanabe-Fukunaga et al., 1992) . In addition, Pten+/7 mice are highly predisposed to the development of thymic lymphomas (Suzuki et al., 1998; Podsypanina et al., 1999) . Moreover, we have recently found that Cd95 and Pten are simultaneously inactivated in a significant faction of the g-radiation-induced thymic lymphomas (Santos et al., 2001) . Taking this evidence into account, it is reasonable to speculate that differences between the Mus spretus and C57BL/6J alleles that would affect the biological functions of any of these genes may differentially influence RITL development. In this sense, it is worth noting that genetic susceptibility to certain mouse tumors, such as plasmacytomas (tumors of mature end-stage B cells), has been associated with strain-specific variation in tumor suppressor gene function (Zhang et al., 2001) . Further structural and functional studies will be needed, however, to elucidate whether functional allelic variation of either Pdcd4, Cd95 or Pten differentially contributes in the control of resistance to RITL.
In summary, data presented here represent the first report on the existence of a thymic lymphoma resistance locus on mouse chromosome 19. The identification of new loci (or haplotypes) conferring resistance to RITL emphasizes the great value of the Mus spretus genome as a source of genetic polymorphism. Here we identified a new locus after analysing only seven chromosomes, it then makes sense to believe that scanning all chromosomes systematically and/or using other inbred strains derived from recently trapped wild specimens of different species of the Mus genus, other loci might be discovered. Our observations also indicate that the generation of ICS and IRCS, which results in a partitioning of the genome, greatly simplify the genetic analysis of cancer predisposition and, in a more general way, the genetic dissection of multigenic traits.
